Resources

Download press release Internationally recognised business executive with extensive operational experience in life sciences, diagnostics and pharma Appointment will lead strategic growth plans, including commercialisation of the gSynth® platform for AI-driven antibody discovery, and operational scaling

Cambridge, UK, 28th April 2026: Chesterford Research Park has secured the first letting at the newly completed Sidney Sussex Building, with Suite 5 (2,910 sq ft) taken by existing occupier Camena Bioscience (Camena).

See full press release.

If healthcare were a country it would be the 5th largest polluter on the planet, representing 4.4% of the global total.

Did you know that today is World Mental Health Day?

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has closed a $10m Series A financing round, led by Mercia.

Divina Newman and Nika Pierre joined the Camena team for 8 weeks over the summer. It was initially 6 but such was their committment to learning and contribution to ongoing projects, we asked them to stay. We're immensely proud of their accomplishments and the programme enriched the whole team. We asked Divina and Nika to share their experiences.

Following its $10 million Series A financing1 earlier in the year, the appointment forms part of the Company’s growth plans to expand commercialisation of its pioneering DNA synthesis platform, gSynth™.

Camena Bioscience signs up for two exciting initiatives, 10,000 Black Interns and In2Science.